WT1 and acute myeloid leukemia: In contrast to the limited frequency (50%) of mutations mentioned above, over-expression of Wilms Tumor 1 (WT1) gene is present in almost 90% of patients with AML and can be measured in peripheral blood with better sensitivity and specificity than in bone marrow.